 Englewood Cliffs, NJ, May 25, 2021 GLOBE NEWSWIRE -- Silo Pharma, Inc. OTCQB: SILO a development stage biopharmaceutical company focused on the use of psychedelics as a therapeutic, is pleased to announce that it has submitted its initial application to list on the NASDAQ Capital Market NASDAQ. 